Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment

By sjmartinez • February 9, 2023

Lynch JP 3rd, Zhanel GG. Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment. Expert Rev Anti Infect Ther. 2023 Feb;21(2):115-126. doi: 10.1080/14787210.2023.2154654. Epub 2022 Dec 12. PMID: 36469648.

Tags: Anti-bacterial agents, bacteremia, daptomycin, linezolid, pneumonia, Publications, Pulmonary, Critical Care & Sleep Medicine, Staphylococcus aureus, vancomycin

Related Posts

Moderators of the Effects of Telehealth Mindfulness-based Interventions for Chronic Pain: A Secondary Responder Analysis of the LAMP Randomized Controlled Trial

Calvert CM, Hagel Campbell EM, Cross LJS, Bangerter A, Bronfort G, Evans R, Meis LA, Haley A, Leininger B, Matthias M, Polusny M, Allen K,[...]

Leveraging scholarship to lead

Moriates C. Leveraging scholarship to lead. J Hosp Med. 2026 Sep 9. doi: 10.1002/jhm.70478. Epub ahead of print. PMID: 42717657.

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]